WINTON GROUP Ltd Has $940,000 Stock Holdings in Kenvue Inc. $KVUE

WINTON GROUP Ltd boosted its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 196.9% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 49,165 shares of the company’s stock after acquiring an additional 32,605 shares during the period. WINTON GROUP Ltd’s holdings in Kenvue were worth $940,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in the business. BlackRock Inc. bought a new stake in shares of Kenvue during the second quarter worth about $2,882,279,000. State Street Corp raised its holdings in shares of Kenvue by 3.5% in the 4th quarter. State Street Corp now owns 118,865,134 shares of the company’s stock worth $2,050,424,000 after acquiring an additional 4,063,257 shares during the last quarter. California State Teachers Retirement System lifted its position in Kenvue by 1,695.1% in the 2nd quarter. California State Teachers Retirement System now owns 56,438,843 shares of the company’s stock valued at $1,078,546,000 after acquiring an additional 53,294,807 shares in the last quarter. Pentwater Capital Management LP bought a new position in Kenvue in the 2nd quarter valued at about $977,094,000. Finally, Geode Capital Management LLC boosted its stake in Kenvue by 0.8% during the 4th quarter. Geode Capital Management LLC now owns 49,862,574 shares of the company’s stock valued at $856,778,000 after purchasing an additional 371,322 shares during the last quarter. 97.64% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of analysts have commented on the company. Barclays boosted their price objective on Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 21st. UBS Group dropped their target price on Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a report on Tuesday, August 11th. Weiss Ratings raised Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, June 15th. Wall Street Zen downgraded Kenvue from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. Finally, Zacks Research lowered Kenvue from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 7th. Three research analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $19.27.

Kenvue Trading Down 0.3%

Shares of Kenvue stock opened at $17.73 on Monday. The firm has a market cap of $34.06 billion, a PE ratio of 20.39, a P/E/G ratio of 1.59 and a beta of 0.46. Kenvue Inc. has a 1 year low of $14.02 and a 1 year high of $20.13. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.01 and a quick ratio of 0.71. The stock has a fifty day moving average price of $19.05 and a 200-day moving average price of $18.23.

Kenvue (NYSE:KVUE) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.31 earnings per share for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.01). The company had revenue of $3.96 billion during the quarter, compared to analysts’ expectations of $3.97 billion. Kenvue had a return on equity of 21.22% and a net margin of 10.76%.Kenvue’s quarterly revenue was up 3.0% compared to the same quarter last year. During the same period last year, the firm posted $0.29 earnings per share. Equities research analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 2nd. Shareholders of record on Monday, September 21st will be given a $0.21 dividend. The ex-dividend date of this dividend is Monday, September 21st. This represents a $0.84 annualized dividend and a yield of 4.7%. Kenvue’s payout ratio is currently 96.55%.

Kenvue Company Profile

Kenvue Inc is a global consumer health company that develops, markets and sells products designed to support everyday health and personal care. Its portfolio spans over-the-counter medicines, skin health and beauty, essential health products, and baby and family care.

The company’s brands include Tylenol, Motrin, Zyrtec and Benadryl in self-care; Neutrogena, Aveeno and Clean & Clear in skin health and beauty; Listerine in oral care; and Johnson’s and Band-Aid in baby care and essential health.